Literature DB >> 2060630

Peptidyl-prolyl cis-trans isomerase activity as studied by dynamic proton NMR spectroscopy.

D Hübner1, T Drakenberg, S Forsén, G Fischer.   

Abstract

Recently the identity of the peptidyl-prolyl cis-trans isomerase (PPIase), which accelerates the cis/trans isomerization of prolyl peptide bonds and cyclophilin, the binding protein for the immunosuppressive drug Cyclosporin A (CsA), was discovered. The PPIase catalysis toward the substrate Suc-Ala-Phe-Pro-Phe-pNA has been studied by 1H NMR spectroscopy. Using the bandshape analysis technique the rate of interconversion between the cis and trans isomers of the substrate could be measured in the presence of PPIase and under equilibrium conditions. The acceleration is inhibited by equimolar amounts of CsA. The results provide evidence that the PPIase catalysis is more complex than a simple exchange between two states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060630     DOI: 10.1016/0014-5793(91)80766-v

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.

Authors:  Sara M Solbak; Tove R Reksten; Victor Wray; Karsten Bruns; Ole Horvli; Arnt J Raae; Petra Henklein; Peter Henklein; Rene Röder; David Mitzner; Ulrich Schubert; Torgils Fossen
Journal:  BMC Struct Biol       Date:  2010-10-04

2.  Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator.

Authors:  Jie Qing; Yaxin Wang; Yuna Sun; Jiaoyan Huang; Wenzhong Yan; Jinglan Wang; Dan Su; Cheng Ni; Jian Li; Zihe Rao; Lei Liu; Zhiyong Lou
Journal:  PLoS Pathog       Date:  2014-10-02       Impact factor: 6.823

3.  The isomerase active site of cyclophilin A is critical for hepatitis C virus replication.

Authors:  Udayan Chatterji; Michael Bobardt; Suganya Selvarajah; Feng Yang; Hengli Tang; Noayo Sakamoto; Gregoire Vuagniaux; Tanya Parkinson; Philippe Gallay
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.